已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Increased Risk of End-Stage Renal Disease in Familial IgA Nephropathy

医学 肾病 内科学 无症状的 胃肠病学 优势比 蛋白尿 肾活检 队列 肾小球肾炎 肾功能 肾 内分泌学 糖尿病
作者
Francesco Paolo Schena,Giuseppina Cerullo,Michele Rossini,Salvatore Giovanni Lanzilotta,Christian D’Altri,Carlo Manno
出处
期刊:Journal of The American Society of Nephrology [American Society of Nephrology]
卷期号:13 (2): 453-460 被引量:68
标识
DOI:10.1681/asn.v132453
摘要

ABSTRACT. Primary IgA nephropathy (IgAN) is characterized by recurrent episodes of macroscopic hematuria accompanied by upper respiratory tract infections or persistent asymptomatic microscopic hematuria with or without proteinuria. IgAN may involve one or more members of a family. Three generations of a cohort of 110 patients with biopsy-proven IgAN, living in Southern Italy, were checked for urinalysis, and the relative risk (RR) of developing the disease was evaluated. A total of 19 unrelated familial, 37 suspected, and 54 sporadic cases of IgAN were identified. Renal survival was estimated by the Kaplan-Meier method for censored data and compared by use of the log-rank test. More than 50% of the patients with IgAN clustered in kindred with more than two probably affected relatives. In 19 unrelated IgAN families, 8 had single-generation (SG) and 11 multigenerational (MG) involvement showing a prevalent vertical transmission of the trait. The RR was 16 times higher in first-degree relatives (odds ratio [OR], 16.4; 95% confidence interval [CI], 5.7 to 47.8; P < 0.0001) and >2 times higher, even if NS, in second-degree relatives (OR, 2.4; 95 % CI, 0.7 to 7.9; P = 0.145). The clinical and histologic picture of familial and sporadic IgAN appeared to be similar. The 20-yr renal survival rate from the apparent onset of the disease was significantly poorer in patients with familial (41%) than in patients with sporadic (94%) IgAN (P = 0.003). Furthermore, 15-yr renal survival from the time of renal biopsy was significantly worse in familial IgAN (P = 0.02); end-stage renal disease was present in 64% of familial and only in 8% of patients with sporadic IgAN. Finally, renal survival was significantly worse in patients belonging to families with SG rather than with MG involvement (P = 0.03). These data show, for the first time, that familial IgAN may be considered a nonbenign disease that occurs frequently in first-degree relatives. Familial IgAN has a poorer outcome than sporadic IgAN. Therefore, an accurate family history and urinalysis in all family members is urgently recommended in clinical practice. This procedure might avoid late referral of subjects with persistent and underestimated urinary abnormalities and late diagnosis of the disease.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
怕黑凤妖完成签到 ,获得积分10
刚刚
Hase发布了新的文献求助30
1秒前
激情的冰绿完成签到 ,获得积分10
1秒前
小旋风完成签到,获得积分10
3秒前
3秒前
3秒前
5秒前
xc完成签到 ,获得积分10
6秒前
罗斌奇发布了新的文献求助20
6秒前
强健的寻云完成签到 ,获得积分10
7秒前
唯唯完成签到 ,获得积分10
9秒前
求求毕业发布了新的文献求助10
9秒前
李博文发布了新的文献求助10
10秒前
tiantianyuan完成签到 ,获得积分10
11秒前
坚定初阳完成签到 ,获得积分10
11秒前
h123完成签到,获得积分10
13秒前
15秒前
epmoct完成签到 ,获得积分0
15秒前
Gideon完成签到,获得积分10
16秒前
隐形曼青的应助被wn666采纳,获得10
16秒前
Wenlia的应助被北风采纳,获得10
19秒前
大力可燕完成签到,获得积分10
19秒前
加兰完成签到,获得积分10
20秒前
李健的粉丝团团长的应助被fcc采纳,获得10
20秒前
20秒前
zero发布了新的文献求助10
20秒前
桐桐的应助被落后乘风采纳,获得10
21秒前
21秒前
小马甲的应助被哈哈采纳,获得10
23秒前
前前前世完成签到,获得积分10
24秒前
Page_Page发布了新的文献求助30
25秒前
十四发布了新的文献求助10
25秒前
科研通AI6.2的应助被fcc采纳,获得10
25秒前
科研人完成签到,获得积分10
28秒前
28秒前
30秒前
Mao完成签到 ,获得积分10
30秒前
科研通AI2S的应助被小旋风采纳,获得10
30秒前
111发布了新的文献求助10
31秒前
wn666发布了新的文献求助10
31秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8165423
求助须知:如何正确求助?哪些是违规求助? 9559005
关于积分的说明 21748579
捐赠科研通 7756086
什么是DOI,文献DOI怎么找? 3428919
关于科研通互助平台的介绍 2553193
邀请新用户注册赠送积分活动 2473473